P406 Splenic and Hepatic Metastasis of Colorectal Cancer: A Case Report and Literature Review Charlotte Verret, MD
The brand names of semaglutide are Ozempic, Wegovy, and Rybelsus
In Eli Lillys Phase 3 TRIUMPH-1 trial (NCT05929066), 2,339 adults without diabetes received once-weekly retatrutide at 4 mg, 9 mg, or 12 mg, or placebo, for 80 weeks, with topline results announced in May 2026
With the benefit of hindsight, it looks like Novo Nordisk may indeed have made a strategic blunder
(B) Hazard ratios and 95% CIs for all-cause and cardiovascular mortality according to ACR for people with diabetes (red) and without (blue)
How Ro Describes Its Wegovy Pill Access Model According to Ro's published materials, the company describes a telehealth evaluation model in which patients submit health information for review by licensed clinicians, who independently determine eligibility and prescribing decisions